These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1571653)

  • 1. The cholesterol controversy.
    Reckless JP
    BMJ; 1992 Mar; 304(6828):712. PubMed ID: 1571653
    [No Abstract]   [Full Text] [Related]  

  • 2. The cholesterol controversy.
    Winder T
    BMJ; 1992 Mar; 304(6828):712-3. PubMed ID: 1571655
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol in perspective.
    Forge BH
    Med J Aust; 1999 Apr; 170(8):385-90. PubMed ID: 10327953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.
    Strandberg TE
    Diabetes Care; 1997 Sep; 20(9):1495-6. PubMed ID: 9283807
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
    Gambhir DS
    Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 8. Health education, health promotion or drugs? Cholesterol and coronary heart disease.
    Colquhoun D
    Med J Aust; 1990 Sep; 153(5):305-6. PubMed ID: 2392086
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol and total mortality: need for larger trials.
    Collins R; Keech A; Peto R; Sleight P; Kjekshus J; Wilhelmsen L; MacMahon S; Shaw J; Simes J; Braunwald E
    BMJ; 1992 Jun; 304(6843):1689. PubMed ID: 1633527
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical inquiries. What levels of cholesterol should be treated for primary prevention?
    Seaton TL; Meadows S
    J Fam Pract; 2002 May; 51(5):423. PubMed ID: 12019047
    [No Abstract]   [Full Text] [Related]  

  • 12. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels.
    Sacks FM; Rouleau JL; Moye LA; Pfeffer MA; Warnica JW; Arnold JM; Nash DT; Brown LE; Sestier F; Rutherford J
    Am J Cardiol; 1995 Mar; 75(8):621-3. PubMed ID: 7887392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholesterol consensus in The Netherlands].
    Erkelens DW
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1564-9. PubMed ID: 3313067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid therapy. Goal and use in prevention of coronary heart disease].
    Windler E; Greten H
    Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol and coronary heart disease: screening and treatment.
    Turner-Boutle M
    Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the relationship between cholesterol lowering and coronary disease event rate.
    Fazio S; Linton MF
    Circulation; 1998 Dec; 98(23):2645-6. PubMed ID: 9843480
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol reduction and coronary artery disease. An overview of clinical trials up to 1986.
    Tikkanen MJ; Pyörälä K
    Drugs; 1988; 36 Suppl 3():27-31. PubMed ID: 3076117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are statins right for you?
    Gorman C
    Time; 2000 Nov; 156(19):102-3. PubMed ID: 11186855
    [No Abstract]   [Full Text] [Related]  

  • 19. The cholesterol controversy.
    Polanska AI; Malik BA
    BMJ; 1992 Mar; 304(6828):712. PubMed ID: 1571652
    [No Abstract]   [Full Text] [Related]  

  • 20. DoH explains thinking behind national service framework for coronary heart disease.
    Boyle R
    BMJ; 2000 Oct; 321(7268):1083. PubMed ID: 11053200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.